Analyst Li Watsek works at CANTOR FITZGERALD and is covering the the Healthcare sector with 43 price targets and ratings documented since 2019 spanning on 8 stocks.
Li Watsek's average stock forecast success ratio is 6.25% with an average time for price targets to be met of 51.63 days.
Most recent stock forecast was given on CRVS, Corvus Pharmaceuticals, Inc at 09-May-2023.
Analyst best performing recommendations are on CRVS (CORVUS PHARMACEUTICALS, INC).
The best stock recommendation documented was for CRVS (CORVUS PHARMACEUTICALS, INC) at 8/3/2021. The price target of $5 was fulfilled within 45 days with a profit of $2.9 (138.1%) receiving and performance score of 30.69.
Currently, out of the existing stock ratings of Li Watsek - 3 which are a Buy (100%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
4
$0.91 (29.45%)
22 days ago
1/4 (25%)
$4.43 (191.22%)
45
Hold
3.5
$0.41 (13.27%)
4
2 months 1 days ago
4/6 (66.67%)
$4.25 (122.33%)
360
Buy
8
$4.91 (158.90%)
1 years 5 months 29 days ago
0/1 (0%)
$4.69 (141.69%)
Buy
8
$4.91 (158.90%)
8
2 years 7 months 26 days ago
2/4 (50%)
$7.36 (143.35%)
454
Buy
15
$11.91 (385.44%)
14
4 years 9 months 16 days ago
3/4 (75%)
$3.03 (31.47%)
76
